Publication | Open Access
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
17
Citations
20
References
2022
Year
A study of epacadostat (INCB024360) in combination with durvalumab (MEDI4736) in subjects with selected advanced solid tumors (ECHO-203) (NCT02318277).
| Year | Citations | |
|---|---|---|
Page 1
Page 1